V019-7644 Screening compound: N-({1-benzyl-2-[(2-fluorophenyl)methanesulfonyl]-1H-imidazol-5-yl}methyl)-N-[2-(morpholin-4-yl)ethyl]benzamide

V019-7644 Screening compound: N-({1-benzyl-2-[(2-fluorophenyl)methanesulfonyl]-1H-imidazol-5-yl}methyl)-N-[2-(morpholin-4-yl)ethyl]benzamide
V019-7644 Screening compound: N-({1-benzyl-2-[(2-fluorophenyl)methanesulfonyl]-1H-imidazol-5-yl}methyl)-N-[2-(morpholin-4-yl)ethyl]benzamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V019-7644
N-({1-benzyl-2-[(2-fluorophenyl)methanesulfonyl]-1H-imidazol-5-yl}methyl)-N-[2-(morpholin-4-yl)ethyl]benzamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V019-7644

Molecular Formula

C31H33FN4O4S (C31 H33 FN4 O4 S)

Compound Name

N-({1-benzyl-2-[(2-fluorophenyl)methanesulfonyl]-1H-imidazol-5-yl}methyl)-N-[2-(morpholin-4-yl)ethyl]benzamide

IUPAC name

N-({1-benzyl-2-[(2-fluorophenyl)methanesulfonyl]-1H-imidazol-5-yl}methyl)-N-[2-(morpholin-4-yl)ethyl]benzamide

SMILES

O=C(c1ccccc1)N(CCN1CCOCC1)Cc(n1Cc2ccccc2)cnc1S(Cc(cccc1)c1F)(=O)=O

InChI

InChI=1S/C31H33FN4O4S/c32-29-14-8-7-13-27(29)24-41(38,39)31-33-21-28(36(31)22-25-9-3-1-4-10-25)23-35(16-15-34-17-19-40-20-18-34)30(37)26-11-5-2-6-12-26/h1-14,21H,15-20,22-24H2

InChI Key

ULBQJVBADDOUGZ-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD19824647

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

576.69

Hydrogen Bond Acceptors Count

9.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

12.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

3.719

Distribution Coefficient, logD

3.713

Water Solubility, LogSw

-3.87

Polar Surface Area

68.460

Acid Dissociation Constant (pKa)

20.02

Base Dissociation Constant (pKb)

5.55

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

29.00

V019-7644 in Drug Discovery

Included in Screening Libraries

Anticancer Library (62698 compounds)

GPCR Targeted Library (31838 compounds)

?ysteine Targeted Covalent Library (39471 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
Targets:
  • GPCR
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with V019-7644 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V019-7644?
Check Price and Availability of V019-7644, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V019-7644 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V019-7644
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V019-7644
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V019-7644 available by request